Thyrocare Technologies Limited

Symbol: THYROCARE.BO

BSE

603.8

INR

Market price today

  • 50.3561

    P/E Ratio

  • 0.9067

    PEG Ratio

  • 31.97B

    MRK Cap

  • 0.03%

    DIV Yield

Thyrocare Technologies Limited (THYROCARE-BO) Stock Price & Analysis

Shares Outstanding

52.95M

Gross Profit Margin

0.71%

Operating Profit Margin

0.15%

Net Profit Margin

0.12%

Return on Assets

0.00%

Return on Equity

0.26%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Healthcare
Industry: Diagnostics & Research
CEO:Mr. Rahul Franklin Guha
Full-time employees:1645
City:Navi Mumbai
Address:D/37-3, TTC Industrial Area

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

General Outlook

In simple terms, Thyrocare Technologies Limited has 52.953 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.708% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.151%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.118%. This tells us they're good at keeping money after all costs.

Return on Investments

Thyrocare Technologies Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.257%.

Stock Prices

Thyrocare Technologies Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $609.35, while its low point bottomed out at $588.2. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Thyrocare Technologies Limited's stock market.

Profitability Ratios

THYROCARE.BO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 16.32% underscores its earnings before tax deductions. The effective tax rate stands at 28.27%, revealing its tax efficiency. The net income per EBT, 72.49%, and the EBT per EBIT, 108.09%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 15.10%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin16.32%
Effective Tax Rate28.27%
Net Income per EBT72.49%
EBT per EBIT108.09%
EBIT per Revenue15.10%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 16.85, and free cash flow per share, 16.85, depict cash generation on a per-share basis. Lastly, the operating cash flow sales ratio, 0.16, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share16.85
Free Cash Flow per Share16.85
Operating Cash Flow Sales Ratio0.16
Free Cash Flow to Operating Cash Flow Ratio1.00
Dividend Payout Ratio0.03

Debt and Leverage Ratios

An interest coverage of 22.28 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage22.28

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 99.53, provides a glimpse into top-line earnings distributed across each share. Net income per share, 12.16, reflects the portion of profit attributed to each share. The book value per share, 100.97, represents the net asset value distributed per share, while the tangible book value per share, 82.04, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share99.53
Net Income Per Share12.16
Book Value Per Share100.97
Tangible Book Value Per Share82.04
Shareholders Equity Per Share100.97
Interest Debt Per Share4.85
Capex Per Share-8.25

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -10.56%, indicates top-line expansion, while the gross profit growth, -13.30%, reveals profitability trends. EBIT growth, -57.66%, and operating income growth, -57.66%, offer insights into operational profitability progression. The net income growth, -63.46%, showcases bottom-line expansion, and the EPS growth, -63.48%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-10.56%
Gross Profit Growth-13.30%
EBIT Growth-57.66%
Operating Income Growth-57.66%
Net Income Growth-63.46%
EPS Growth-63.48%
EPS Diluted Growth-63.48%
Weighted Average Shares Growth0.06%
Weighted Average Shares Diluted Growth0.05%
Dividends per Share Growth-0.01%
Operating Cash Flow Growth14.02%
Free Cash Flow Growth13.34%
5-Year Revenue Growth per Share50.06%
3-Year Revenue Growth per Share21.03%
5-Year Operating CF Growth per Share22.66%
3-Year Operating CF Growth per Share-23.13%
5-Year Net Income Growth per Share-29.95%
3-Year Net Income Growth per Share-27.34%
5-Year Shareholders Equity Growth per Share22.37%
3-Year Shareholders Equity Growth per Share45.43%
5-Year Dividend per Share Growth per Share49.96%
3-Year Dividend per Share Growth per Share-39.99%
Receivables Growth-9.32%
Inventory Growth12.80%
Asset Growth4.12%
Book Value per Share Growth1.41%
Debt Growth12.61%
SGA Expenses Growth9.98%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 22,794,188,113.4, captures the company's total value, considering both debt and equity. Income quality, 1.48, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 15.97%, indicates the value of non-physical assets, and capex to operating cash flow, -33.76%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value22,794,188,113.4
Income Quality1.48
Sales General and Administrative to Revenue0.04
Intangibles to Total Assets15.97%
Capex to Operating Cash Flow-33.76%
Capex to Revenue-8.29%
Capex to Depreciation-112.76%
Stock-Based Compensation to Revenue4.02%
Graham Number166.22
Return on Tangible Assets12.11%
Graham Net Net22.80
Working Capital1,958,400,000
Tangible Asset Value4,341,500,000
Net Current Asset Value1,754,400,000
Average Receivables900,750,000
Average Payables202,600,000
Average Inventory261,000,000
Days Sales Outstanding59
Days Payables Outstanding54
Days of Inventory On Hand62
ROIC10.82%
ROE0.12%

Valuation Ratios

The price to sales ratio, 5.96, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 36.96, and price to operating cash flows, 36.96, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price to Sales Ratio5.96
Price Cash Flow Ratio36.96
Price Earnings to Growth Ratio0.91
Enterprise Value Multiple24.82
Price to Operating Cash Flow Ratio36.96
Price to Free Cash Flows Ratio36.96
Price to Tangible Book Ratio4.26
Enterprise Value to Sales4.33
Enterprise Value Over EBITDA18.40
EV to Operating Cash Flow17.63
Earnings Yield2.83%
Free Cash Flow Yield3.77%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Thyrocare Technologies Limited (THYROCARE.BO) on the BSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 50.356 in 2024.

What is the ticker symbol of Thyrocare Technologies Limited stock?

The ticker symbol of Thyrocare Technologies Limited stock is THYROCARE.BO.

What is company IPO date?

IPO date of Thyrocare Technologies Limited is N/A.

What is company current share price?

Current share price is 603.800 INR.

What is stock market cap today?

The market cap of stock today is 31972840260.000.

What is PEG ratio in 2024?

The current 0.907 is 0.907 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1645.